Regencell Bioscience Holdings Limited
RGC
Updated: 23/09/2026, 13:44:06
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
No summaries found.
- Share price
- $6.23
- Market cap
- $3.09B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Yat-Gai Au
- Employees
- 10
- IPO date
- 16/07/2021
- Beta
- 1.43
- Last dividend
- $0.00
- Day range
- $5.86 – $6.27
- 52-week range
- $4.51 – $69.00
- 1-day performance
- 5.24%
- 1-year performance
- 38.14%
- Current drawdown (1Y)
- -90.97%
- CIK
- 0001829667
- CUSIP
- G7487R100
- ISIN
- KYG7487R1002
- Created
- 07/12/2025, 13:58:52
- Last update
- 23/09/2026, 13:44:06
Track Regencell Bioscience Holdings Limited with an AI analyst
See which prediction-market events move RGC, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
REGENCELL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action - RGC
Newsfile Corp • STOCK • 14/06/2026, 20:17:00
Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewsWire • STOCK • 14/06/2026, 14:00:00
REGENCELL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important June 23 Deadline in Securities Class Action - RGC
Newsfile Corp • STOCK • 13/06/2026, 11:19:00
RGC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
GlobeNewsWire • STOCK • 13/06/2026, 10:20:00
RGC Deadline: RGC Investors with Losses in Excess of $100K Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit
PRNewsWire • STOCK • 12/06/2026, 19:51:00
Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PRNewsWire • STOCK • 12/06/2026, 17:54:00
RGC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regencell Bioscience Holdings Limited Securities Lawsuit - Contact The Gross Law Firm
GlobeNewsWire • STOCK • 12/06/2026, 13:46:00
REGENCELL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important June 23 Deadline in Securities Class Action - RGC
Newsfile Corp • STOCK • 11/06/2026, 21:04:00
RGC SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
Newsfile Corp • STOCK • 11/06/2026, 20:55:00
Deadline Alert: Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
GlobeNewsWire • STOCK • 11/06/2026, 14:00:00
REGENCELL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important June 23 Deadline in Securities Class Action - RGC
Newsfile Corp • STOCK • 10/06/2026, 18:16:00
DEADLINE ALERT for RGC, SES, FSK, GPK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
Globe News Wire • STOCK • 10/06/2026, 15:03:50